<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">ZIKV </span>
   <span class="font21">ZIKV-E </span>
   <span class="font17">mice </span>
   <span class="font16">using </span>
   <span class="font16">virus </span>
   <span class="font16">antibodies </span>
   <span class="font16">protein </span>
   <span class="font15">Zika </span>
   <span class="font15">NPs </span>
   <span class="font15">vaccine </span>
   <span class="font15">immune </span>
   <span class="font14">DENV </span>
   <span class="font14">titres </span>
   <span class="font14">[]. </span>
   <span class="font14">serum </span>
   <span class="font14">DENV- </span>
   <span class="font14">ADE </span>
   <span class="font13">[], </span>
   <span class="font13">infection </span>
   <span class="font13">mAb </span>
   <span class="font13">anti-ZIKV-E </span>
   <span class="font13">nAb </span>
   <span class="font13">EDIII </span>
   <span class="font13">Fig. </span>
   <span class="font13">recombinant </span>
   <span class="font13">(Fig. </span>
   <span class="font13">purified </span>
   <span class="font12">data </span>
   <span class="font12">group </span>
   <span class="font12">prM </span>
   <span class="font12">antiserum </span>
   <span class="font12">dengue </span>
   <span class="font12">sera </span>
   <span class="font12">cells </span>
   <span class="font12">µl)’ </span>
   <span class="font12">day </span>
   <span class="font12">pastoris </span>
   <span class="font12">significant </span>
   <span class="font12">{border-style </span>
   <span class="font11">antibody </span>
   <span class="font11">dose </span>
   <span class="font11">human </span>
   <span class="font11">shown </span>
   <span class="font11">EDIII-specific </span>
   <span class="font11">ELISA </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">absence </span>
   <span class="font11">different </span>
   <span class="font11">groups </span>
   <span class="font11">mouse </span>
   <span class="font11">proteins </span>
   <span class="font11">survival </span>
   <span class="font11">BALB/c </span>
   <span class="font11">Stat−/− </span>
   <span class="font11">analysis </span>
   <span class="font11">described </span>
   <span class="font11">efficacy </span>
   <span class="font11">induced </span>
   <span class="font11">pooled </span>
   <span class="font11">(Supplementary </span>
   <span class="font11">analysed </span>
   <span class="font11">based </span>
   <span class="font11">challenge </span>
   <span class="font11">elicited </span>
   <span class="font11">lethal </span>
   <span class="font11">particles </span>
   <span class="font11">solid </span>
   <span class="font11">‘α-ZIKV-E </span>
   <span class="font11">CBL/ </span>
   <span class="font11">File, </span>
   <span class="font11">NPs, </span>
   <span class="font11">S). </span>
   <span class="font11">days </span>
   <span class="font11">envelope </span>
   <span class="font11">indirect </span>
   <span class="font11">obtained </span>
   <span class="font11">particle </span>
   <span class="font11">potent </span>
   <span class="font11">protection </span>
   <span class="font11">received </span>
   <span class="font11">serotypes </span>
   <span class="font11">DENV-E </span>
   <span class="font11">[,]. </span>
   <span class="font11">clinical </span>
   <span class="font11">levels </span>
   <span class="font11">luciferase </span>
   <span class="font11">purple </span>
   <span class="font11">specific </span>
   <span class="font11">vitro </span>
   <span class="font11">vivo </span>
   <span class="font11">DENVs </span>
   <span class="font11">challenged </span>
   <span class="font11">curves </span>
   <span class="font11">determined </span>
   <span class="font11">display </span>
   <span class="font11">domain </span>
   <span class="font11">enhancement </span>
   <span class="font11">expressed </span>
   <span class="font11">expression </span>
   <span class="font11">following </span>
   <span class="font11">highly </span>
   <span class="font11">lack </span>
   <span class="font11">protective </span>
   <span class="font11">recognised </span>
   <span class="font11">study </span>
   <span class="font11">virus-like </span>
   <span class="font11">weight </span>
   <span class="font11">However, </span>
   <span class="font11">assay </span>
   <span class="font11">capable </span>
   <span class="font11">cross-reactive </span>
   <span class="font11">enhance </span>
   <span class="font11">mAbs </span>
   <span class="font11">model </span>
   <span class="font11">neutralising </span>
   <span class="font11">observed </span>
   <span class="font11">panel </span>
   <span class="font11">pastoris-expressed </span>
   <span class="font11">potential </span>
   <span class="font11">self-assemble </span>
   <span class="font11">similar </span>
   <span class="font11">strain </span>
   <span class="font11">sub-lethal </span>
   <span class="font11">used </span>
   <span class="font10">(Methods </span>
   <span class="font10">Data </span>
   <span class="font10">Pichia </span>
   <span class="font10">RVP </span>
   <span class="font10">VLPs </span>
   <span class="font10">ZIKV-specific </span>
   <span class="font10">ZV- </span>
   <span class="font10">absorbance </span>
   <span class="font10">activity </span>
   <span class="font10">assessed </span>
   <span class="font10">capacity </span>
   <span class="font10">curve) </span>
   <span class="font10">did </span>
   <span class="font10">dilution </span>
   <span class="font10">experiment </span>
   <span class="font10">flavivirus </span>
   <span class="font10">gene </span>
   <span class="font10">grey </span>
   <span class="font10">higher </span>
   <span class="font10">immunised </span>
   <span class="font10">infection. </span>
   <span class="font10">mice. </span>
   <span class="font10">neutralizing </span>
   <span class="font10">polyclonal </span>
   <span class="font10">protein. </span>
   <span class="font10">proteins, </span>
   <span class="font10">revealed </span>
   <span class="font10">single </span>
   <span class="font10">viremia </span>
   <span class="font10">Mice </span>
   <span class="font10">Thus, </span>
   <span class="font10">Western </span>
   <span class="font10">associated </span>
   <span class="font10">coating </span>
   <span class="font10">depletion </span>
   <span class="font10">displayed </span>
   <span class="font10">function </span>
   <span class="font10">high </span>
   <span class="font10">homotypic </span>
   <span class="font10">loop </span>
   <span class="font10">murine </span>
   <span class="font10">neutralisation </span>
   <span class="font10">peaks </span>
   <span class="font10">purification </span>
   <span class="font10">px; </span>
   <span class="font10">recent </span>
   <span class="font10">serum, </span>
   <span class="font10">severe </span>
   <span class="font10">significantly </span>
   <span class="font10">sub-neutralising </span>
   <span class="font10">terms </span>
   <span class="font10">test </span>
   <span class="font10">transfer </span>
   <span class="font10">{font-family </span>
   <span class="font10">(a) </span>
   <span class="font10">(b) </span>
   <span class="font10">(in </span>
   <span class="font10">Determination </span>
   <span class="font10">EDIII, </span>
   <span class="font10">III </span>
   <span class="font10">MBP-ZIKV </span>
   <span class="font10">Med </span>
   <span class="font10">NP-induced </span>
   <span class="font10">NPs. </span>
   <span class="font10">Trop </span>
   <span class="font10">antisera </span>
   <span class="font10">bled </span>
   <span class="font10">candidates </span>
   <span class="font10">cell </span>
   <span class="font10">compared </span>
   <span class="font10">corresponding </span>
   <span class="font10">difference </span>
   <span class="font10">efficient </span>
   <span class="font10">epitopes </span>
   <span class="font10">font-size </span>
   <span class="font10">group, </span>
   <span class="font10">host </span>
   <span class="font10">indicated </span>
   <span class="font10">infect </span>
   <span class="font10">integrity </span>
   <span class="font10">manifest </span>
   <span class="font10">mice, </span>
   <span class="font10">plasma </span>
   <span class="font10">possess </span>
   <span class="font10">possible </span>
   <span class="font10">residues </span>
   <span class="font10">respectively. </span>
   <span class="font10">sequence </span>
   <span class="font10">strains </span>
   <span class="font10">tested </span>
   <span class="font10">titre </span>
   <span class="font10">titres, </span>
   <span class="font10">total </span>
   <span class="font10">(NT </span>
   <span class="font10">(mouse </span>
   <span class="font10">.), </span>
   <span class="font10">DENV-, </span>
   <span class="font10">EDIIIs </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">RNA </span>
   <span class="font10">Survival </span>
   <span class="font10">ZV-, </span>
   <span class="font10">ability </span>
   <span class="font10">anti-DENV- </span>
   <span class="font10">antigen. </span>
   <span class="font10">antigenic </span>
   <span class="font10">appears </span>
   <span class="font10">carried </span>
   <span class="font10">challenge. </span>
   <span class="font10">comparable </span>
   <span class="font10">control </span>
   <span class="font10">dashed </span>
   <span class="font10">differences </span>
   <span class="font10">disease </span>
   <span class="font10">does </span>
   <span class="font10">double; </span>
   <span class="font10">efficiently </span>
   <span class="font10">elicit </span>
   <span class="font10">epitope </span>
   <span class="font10">examined </span>
   <span class="font10">experiment, </span>
   <span class="font10">fraction </span>
   <span class="font10">fractions </span>
   <span class="font10">fusion </span>
   <span class="font10">given </span>
   <span class="font10">included </span>
   <span class="font10">infection, </span>
   <span class="font10">live </span>
   <span class="font10">multiple </span>
   <span class="font10">panels </span>
   <span class="font10">passive </span>
   <span class="font10">peptide </span>
   <span class="font10">predominantly </span>
   <span class="font10">presence </span>
   <span class="font10">recall </span>
   <span class="font10">reporter </span>
   <span class="font10">showed </span>
   <span class="font10">statistically </span>
   <span class="font10">structural </span>
   <span class="font10">suggest </span>
   <span class="font10">symptoms </span>
   <span class="font10">taken </span>
   <span class="font10">vaccines </span>
   <span class="font10">µl) </span>
   <span class="font10">(c) </span>
   <span class="font10">(d) </span>
   <span class="font10">.). </span>
   <span class="font10">Dengue </span>
   <span class="font10">EDIII. </span>
   <span class="font10">Infect </span>
   <span class="font10">Microbiol </span>
   <span class="font10">N-terminal </span>
   <span class="font10">Ni-NTA </span>
   <span class="font10">Recombinant </span>
   <span class="font10">Renilla </span>
   <span class="font10">SS, </span>
   <span class="font10">Supplementary </span>
   <span class="font10">a). </span>
   <span class="font10">accessible </span>
   <span class="font10">address </span>
   <span class="font10">assay, </span>
   <span class="font10">assay. </span>
   <span class="font10">assembly </span>
   <span class="font10">b). </span>
   <span class="font10">blot </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collected </span>
   <span class="font10">cross-reactivity </span>
   <span class="font10">curve). </span>
   <span class="font10">denaturing </span>
   <span class="font10">denotes </span>
   <span class="font10">development </span>
   <span class="font10">earlier </span>
   <span class="font10">encoding </span>
   <span class="font10">followed </span>
   <span class="font10">generated </span>
   <span class="font10">group; </span>
   <span class="font10">i.p. </span>
   <span class="font10">imidazole </span>
   <span class="font10">immunisation </span>
   <span class="font10">inactivated </span>
   <span class="font10">infection-enhancing </span>
   <span class="font10">infections </span>
   <span class="font10">later </span>
   <span class="font10">light </span>
   <span class="font10">like </span>
   <span class="font10">likely </span>
   <span class="font10">lower </span>
   <span class="font10">mock-immunised </span>
   <span class="font10">monitored </span>
   <span class="font10">nAbs </span>
   <span class="font10">number </span>
   <span class="font10">pathogenic </span>
   <span class="font10">performed </span>
   <span class="font10">potential. </span>
   <span class="font10">pre-incubated </span>
   <span class="font10">presented </span>
   <span class="font10">promote </span>
   <span class="font10">protein, </span>
   <span class="font10">reported </span>
   <span class="font10">result </span>
   <span class="font10">size </span>
   <span class="font10">solid; </span>
   <span class="font10">structures </span>
   <span class="font10">vaccine, </span>
   <span class="font10">vector </span>
   <span class="font10">virus, </span>
   <span class="font10">vivo, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(dashed </span>
   <span class="font10">(day </span>
   <span class="font10">(solid </span>
   <span class="font10">C–C’ </span>
   <span class="font10">DLS </span>
   <span class="font10">EDIII-focused </span>
   <span class="font10">FLE </span>
   <span class="font10">HBV </span>
   <span class="font10">Immunol </span>
   <span class="font10">India. </span>
   <span class="font10">MBP </span>
   <span class="font10">Mantel–Cox </span>
   <span class="font10">N-glycan </span>
   <span class="font10">NP-immunised </span>
   <span class="font10">RS, </span>
   <span class="font10">Schematic </span>
   <span class="font10">Table </span>
   <span class="font10">Taken </span>
   <span class="font10">USA. </span>
   <span class="font10">ZIKV-infected </span>
   <span class="font10">[,] </span>
   <span class="font10">[]]. </span>
   <span class="font10">[α-ZIKV-E </span>
   <span class="font10">administered </span>
   <span class="font10">advantage </span>
   <span class="font10">affinity </span>
   <span class="font10">aliquot </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antibody-dependent </span>
   <span class="font10">antigen </span>
   <span class="font10">arrow </span>
   <span class="font10">article </span>
   <span class="font10">average </span>
   <span class="font10">black </span>
   <span class="font10">blue </span>
   <span class="font10">bold </span>
   <span class="font10">c). </span>
   <span class="font10">candidate </span>
   <span class="font10">cause </span>
   <span class="font10">cells, </span>
   <span class="font10">conclusion </span>
   <span class="font10">conditions </span>
   <span class="font10">confer </span>
   <span class="font10">conformational </span>
   <span class="font10">courier; </span>
   <span class="font10">cross-react </span>
   <span class="font10">culture </span>
   <span class="font10">curve, </span>
   <span class="font10">defined </span>
   <span class="font10">demonstrated </span>
   <span class="font10">depict </span>
   <span class="font10">design </span>
   <span class="font10">despite </span>
   <span class="font10">dilution, </span>
   <span class="font10">discrete </span>
   <span class="font10">distinct </span>
   <span class="font10">documented </span>
   <span class="font10">effective </span>
   <span class="font10">eliciting </span>
   <span class="font10">em; </span>
   <span class="font10">evaluated </span>
   <span class="font10">evidence </span>
   <span class="font10">experiments </span>
   <span class="font10">fetal </span>
   <span class="font10">future </span>
   <span class="font10">group) </span>
   <span class="font10">hand, </span>
   <span class="font10">humans </span>
   <span class="font10">immobilised </span>
   <span class="font10">infectious </span>
   <span class="font10">interesting </span>
   <span class="font10">lead </span>
   <span class="font10">linked </span>
   <span class="font10">log </span>
   <span class="font10">loss </span>
   <span class="font10">low </span>
   <span class="font10">mentioned </span>
   <span class="font10">mock-immune </span>
   <span class="font10">mortality </span>
   <span class="font10">neutralise </span>
   <span class="font10">new </span>
   <span class="font10">outbreaks </span>
   <span class="font10">overall </span>
   <span class="font10">platforms </span>
   <span class="font10">post-challenge </span>
   <span class="font10">pre-incubating </span>
   <span class="font10">pre-membrane </span>
   <span class="font10">pt;} </span>
   <span class="font10">quite </span>
   <span class="font10">range </span>
   <span class="font10">recognition </span>
   <span class="font10">reduction </span>
   <span class="font10">reference </span>
   <span class="font10">represent </span>
   <span class="font10">representation </span>
   <span class="font10">resulted </span>
   <span class="font10">resulting </span>
   <span class="font10">right </span>
   <span class="font10">role </span>
   <span class="font10">safety </span>
   <span class="font10">signal </span>
   <span class="font10">starting </span>
   <span class="font10">subtle </span>
   <span class="font10">synthetic </span>
   <span class="font10">test). </span>
   <span class="font10">this, </span>
   <span class="font10">time </span>
   <span class="font10">titration </span>
   <span class="font10">together, </span>
   <span class="font10">transmission </span>
   <span class="font10">type </span>
   <span class="font10">values </span>
   <span class="font10">viruses </span>
   <span class="font10">vivo. </span>
   <span class="font10">work </span>
   <span class="font10">µl/mouse </span>
   <span class="font10">‘Un-infected’ </span>
   <span class="font10">‘a’ </span>
  </p>
 </body>
</html>
